Recently, it was reported that point mutations in human pachygyria patients (Reelin Y1821H, G1280E, and R913C) showed stronger activity than wild-type Reelin when overexpressed in embryonic mouse brains (Riva et al., 2024). Here, RELN is linked to Pachygyria.